GET1
Guided entry of tail-anchored proteins factor 1
Also known as: CHD5, GET1_HUMAN, WRB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00258
- Gene
- GET1
- Ensembl
- ENSG00000182093
- Chromosome
- 21
- Canonical length
- 174 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is located in the candidate region for congenital heart disease (CHD) in Down syndrome (DS). It encodes a basic protein that functions as a receptor that promotes insertion of tail-anchored proteins in the endoplasmic reticulum membrane. This gene is located at a maternally-methylated differentially methylated region (DMR); however, its transcription may be biallelic, not imprinted. Alternative splicing results in different transcript variants. A pseudogene has been defined on chromosome 4. [provided by RefSeq, Apr 2017]
Canonical amino-acid sequenceUniProt
174 residues, UniProt reviewed canonical sequence.
>O00258|GET1
1 MSSAAADHWA WLLVLSFVFG CNVLRILLPS FSSFMSRVLQ KDAEQESQMR AEIQDMKQEL
61 STVNMMDEFA RYARLERKIN KMTDKLKTHV KARTAQLAKI KWVISVAFYV LQAALMISLI
121 WKYYSVPVAV VPSKWITPLD RLVAFPTRVA GGVGITCWIL VCNKVVAIVL HPFSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GET1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 135 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 135 nTPM
- retina: 103 nTPM
- hypothalamus: 85 nTPM
- spinal cord: 84 nTPM
- amygdala: 76 nTPM
- cerebral cortex: 75 nTPM
Single-cell type
- ependymal cells: 84 nCPM
- choroid plexus epithelial cells: 64 nCPM
- other brain neurons: 63 nCPM
- podocytes: 63 nCPM
- oligodendrocytes: 55 nCPM
- brain inhibitory neurons: 45 nCPM
Immune cell
- neutrophil: 47 nTPM
- plasmacytoid DC: 40 nTPM
- total PBMC: 40 nTPM
- basophil: 38 nTPM
- memory B-cell: 31 nTPM
- myeloid DC: 31 nTPM
Brain region
- choroid plexus: 92 nTPM
- hypothalamus: 75 nTPM
- white matter: 65 nTPM
- pons: 59 nTPM
- midbrain: 57 nTPM
- spinal cord: 54 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.16
- gnomAD pLI
- 1
- DepMap mean gene effect
- -0.29
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- establishment of localization in cell
- otic vesicle development
- post-translational protein targeting to endoplasmic reticulum membrane
- protein insertion into ER membrane
- protein stabilization
- sensory perception of sound
- synapse organization
- tail-anchored membrane protein insertion into ER membrane
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Helix hairpin bin domain superfamily
- Get1 family
- CHD5-like protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GET1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GET1 as an antibody target. Whether an autoantibody or antibody against GET1 could matter depends on whether native GET1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GET1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GET1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...